Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Moderate Pain - Pipeline Review, H2 2013

% of readers think this story is Fact. Add your two cents.


Moderate Pain – Pipeline Review, H2 2013

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with (Moderate Pain – Pipeline Review Market) in subject line and your contact details.

Moderate Pain – Pipeline Review, H2 2013, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Moderate Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Moderate Pain. Moderate Pain – Pipeline Review, Half Year is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Scope of the Report

- A snapshot of the global therapeutic scenario for Moderate Pain.
- A review of the Moderate Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Moderate Pain pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Complete report is spread across 64 pages is available @ http://www.reportsnreports.com/reports/271743-moderate-pain-pipeline-review-h2-2013.html.

Reasons to Buy the Report Moderate Pain – Pipeline Review, H2 2013

- Identify and understand important and diverse types of therapeutics under development for Moderate Pain.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Moderate Pain pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=271743.

List of Tables
Number of Products Under Development for Moderate Pain, H2 2013 8
Products under Development for Moderate Pain – Comparative Analysis, H2 2013 9
Number of Products under Development by Companies, H2 2013 11
Comparative Analysis by Late Stage Development, H2 2013 12
Comparative Analysis by Mid Clinical Stage Development, H2 2013 13
Comparative Analysis by Early Clinical Stage Development, H2 2013 14
Comparative Analysis by Pre-Clinical Stage Development, H2 2013 15
Products under Development by Companies, H2 2013 16
Nektar Therapeutics, H2 2013 17
Esteve Group, H2 2013 18
Pain Therapeutics, Inc., H2 2013 19
Pfizer Inc., H2 2013 20
Menarini Group, H2 2013 21
Acura Pharmaceuticals, Inc., H2 2013 22
Elite Pharmaceuticals, Inc., H2 2013 23
Charleston Laboratories, Inc., H2 2013 24
Trevena, Inc., H2 2013 25
QRxPharma Limited, H2 2013 26
KemPharm, Inc., H2 2013 27
TheraQuest Biosciences, LLC, H2 2013 28
Assessment by Monotherapy Products, H2 2013 29
Assessment by Combination Products, H2 2013 30
Assessment by Stage and Route of Administration, H2 2013 32
Assessment by Stage and Molecule Type, H2 2013 34
Moderate Pain Therapeutics – Drug Profile Updates 54
Moderate Pain Therapeutics – Discontinued Products 58
Moderate Pain Therapeutics – Dormant Products 59

Inquiry Before Buying @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=271743

List of Figures
Number of Products under Development for Moderate Pain, H2 2013 8
Products under Development for Moderate Pain – Comparative Analysis, H2 2013 9
Products under Development by Companies, H2 2013 10

Late Stage Products, H2 2013 12
Mid Clinical Stage Products, H2 2013 13
Early Clinical Stage Products, H2 2013 14
Pre-Clinical Stage Products, H2 2013 15
Assessment by Monotherapy Products, H2 2013 29
Assessment by Combination Products, H2 2013 30
Assessment by Route of Administration, H2 2013 31
Assessment by Stage and Route of Administration, H2 2013 32
Assessment by Molecule Type, H2 2013 33
Assessment by Stage and Molecule Type, H2 2013 34

Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=271743.

Explore Report on Pharmaceuticals Market.

Contact [email protected] / Call +1 888 391 5441 for further information on “Moderate Pain – Pipeline Review, H2 2013” report OR for any other market research and intelligence needs you may have for your business.



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse
Loading...

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.